Clinical Trial Update: Effect of TCC Cocktail Combined With TACE Versus TACE Alone on Survival in uHCC Patients

View source ↗

Summary

This is a completed clinical trial evaluating whether adding TCC Cocktail to transarterial chemoembolization (TACE) improves survival in unresectable hepatocell…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• TCC Cocktail

Snippet

Sponsor: Shanghai Zhongshan Hospital | Conditions: Hepatocellular Cancer (HCC) | Status: COMPLETED